. Objectifs-de-santé-publique, Evaluation des objectifs de la loi du 9 août, 2004.

D. Sur,

B. Weinberger, Adult vaccination against tetanus and diphtheria: the European perspective, Clin Exp Immunol. 9 juin, 2016.

S. Esposito, P. Bonanni, M. S. Tan, L. Ansaldi, F. Lopalco et al., Recommended immunization schedules for adults: Clinical practice guidelines by the Escmid Vaccine Study Group (EVASG), European Geriatric Medicine Society (EUGMS) and the World Association for Infectious Diseases and Immunological Disorders (WAidid). Hum Vaccines Immunother. 2 juill, vol.12, pp.1777-94, 2016.

, Calendrier des vaccinations et recommandations vaccinales, 2016.

D. Sur,

, Couverture vaccinale en Limousin en 2013. Plaquette

D. Sur,

G. Berrut, L. Decker, and . De, Immunosénescence : une revue, Gériatrie Psychol Neuropsychiatr Vieil. 1 sept, vol.13, issue.2, pp.7-14, 2015.

C. Bonnal, C. Desaint, A. Raynaud-simon, V. Fossey-diaz, M. L. Gougeon et al., Vaccination des sujets âgés de plus de 65 ans : un enjeu stratégique pour les années futures ! Presse Médicale, mars, vol.42, issue.3, pp.318-344, 2013.

A. J. Pierre and . Comite-«-avancee-en-age-», , p.132

L. Simonsen, R. J. Taylor, C. Viboud, M. A. Miller, and L. A. Jackson, Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis, vol.7, pp.658-66, 2007.

D. Rivetti, T. Jefferson, R. Thomas, M. Rudin, A. Rivetti et al., Vaccines for preventing influenza in the elderly, Cochrane Database Syst Rev, issue.3, p.4876, 2006.

A. T. Curns, R. C. Holman, J. J. Sejvar, M. F. Owings, and L. B. Schonberger, Infectious disease hospitalizations among older adults in the United States from, Arch Intern Med, vol.165, issue.21, pp.2514-2534, 1990.

M. H. Kollef, A. Shorr, Y. P. Tabak, V. Gupta, L. Z. Liu et al., Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia, Chest. déc, vol.128, issue.6, pp.3854-62, 2005.

D. S. Fedson and C. Liss, Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults, Vaccine. 25 févr, vol.22, issue.8, pp.927-973, 2004.

R. N. Greenberg, A. Gurtman, R. W. Frenck, C. Strout, K. U. Jansen et al., Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naïve adults 60-64 years of age, Vaccine. 25 avr, vol.32, issue.20, pp.2364-74, 2014.

L. A. Jackson, K. M. Neuzil, O. Yu, P. Benson, W. E. Barlow et al., Effectiveness of pneumococcal polysaccharide vaccine in older adults, N Engl J Med. 1 mai, vol.348, issue.18, pp.1747-55, 2003.

L. A. Jackson, A. Gurtman, M. Van-cleeff, R. W. Frenck, J. Treanor et al., Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older, Vaccine. 2 août, vol.31, issue.35, pp.3594-602, 2013.

S. Tomczyk, N. M. Bennett, C. Stoecker, R. Gierke, M. R. Moore et al., Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ?65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Morb Mortal Wkly Rep. 19 sept, vol.63, issue.37, pp.822-827, 2014.

. Le-tétanos-en-france-en, , 2000.

D. Sur,

I. J. Amanna, N. E. Carlson, and M. K. Slifka, Duration of humoral immunity to common viral and vaccine antigens, N Engl J Med, vol.357, pp.1903-1918, 2007.

J. Guthmann, L. Fonteneau, D. Antona, and D. Lévy-bruhl, Déterminants de couverture vaccinale antitétanique chez l'adulte en France et de connaissance du statut vaccinal. Médecine Mal Infect, vol.40, pp.560-567, 2010.

B. Loevinsohn, B. Aylward, R. Steinglass, E. Ogden, T. Goodman et al., Impact of targeted programs on health systems: a case study of the polio eradication initiative, Am J Public Health. janv, vol.92, issue.1, pp.19-23, 2002.

M. Rey, Vers l'éradication mondiale de la poliomyélite, p.3

A. A. Gershon, M. D. Gershon, J. Breuer, M. J. Levin, A. L. Oaklander et al., Advances in the understanding of the pathogenesis and epidemiology of herpes zoster, J Clin Virol Off Publ Pan Am Soc Clin Virol. mai, vol.48, issue.1, pp.2-7, 2010.

S. L. Thomas, J. G. Wheeler, and A. J. Hall, Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study, Lancet Lond Engl. 31 août, vol.360, issue.9334, pp.678-82, 2002.

S. Pinchinat, A. M. Cebrián-cuenca, H. Bricout, and R. W. Johnson, Similar herpes zoster incidence across Europe: results from a systematic literature review, BMC Infect Dis. 10 avr, vol.13, p.170, 2013.

R. Sentinelles and &. France,

D. Sur,

G. Mick, J. Gallais, F. Simon, S. Pinchinat, K. Bloch et al., Burden of herpes zoster and postherpetic neuralgia: Incidence, proportion, and associated costs in the French population

, Rev Epidemiol Sante Publique. déc, vol.58, issue.6, pp.393-401, 2010.

D. Bouhassira, O. Chassany, J. Gaillat, T. Hanslik, O. Launay et al., Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice, Pain. févr, vol.153, issue.2, pp.342-351, 2012.

P. Lang, J. Belmin, and J. Michel, Zona des sujets âgés. Presse Médicale. avr, vol.38, issue.4, pp.571-83, 2009.

, Vaccination des adultes contre le zona avec le vaccin Zostavax®, HCSP

. Paris, Haut Conseil de la Santé Publique, 2013.

M. N. Oxman, M. J. Levin, G. R. Johnson, K. E. Schmader, S. E. Straus et al., A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults, N Engl J Med. 2 juin, vol.352, issue.22, pp.2271-84, 2005.

K. E. Schmader, M. N. Oxman, M. J. Levin, G. Johnson, J. H. Zhang et al., Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.55, issue.10, pp.1320-1328, 2012.

R. Aspinall and P. O. Lang, Vaccine responsiveness in the elderly: best practice for the clinic, Expert Rev Vaccines. 1 juill, vol.13, issue.7, pp.885-94, 2014.

A. Fisch, La vaccination du sujet âgé, NPG Neurol -Psychiatr -Gériatrie. déc, vol.4, issue.24, pp.22-28, 2004.

F. Enquête-nationale-de-la-couverture-vaccinale-en, , 2011.

A. De-la-demographie and . Medicale, , p.326, 2016.

C. Vanhaecke-collard, N. Mahmoudi, and R. ,

, Geriatr Psychol Neuropsychiatr Vieil. mars, vol.11, issue.1, pp.7-14, 2013.

C. Poinas, Freins et leviers de la vaccination contre le zona en médecine générale: étude qualitative auprès des médecins généralistes installés dans la Loire

, Université du droit et de la santé, 2017.

, 40. vaccination-antigrippale-prevention_assurance-maladie

D. Sur,

, Résumé : étude épidémiologique sur la couverture vaccinale du sujet de 75 ans et plus, en cabinet de médecine générale

, Contexte : la couverture vaccinale du sujet âgé n'a

, Objectif : décrire le pourcentage de patients de 75 ans et plus suivis en médecine générale en Picardie, ayant un calendrier vaccinal à jour

, Matériel et méthode : étude de 200 dossiers patients chez 20 médecins généralistes installés en Picardie, pp.2017-2018

. Résultats, Notre étude retrouve 75 (37,5%) dossiers sans aucune information disponible. Les régressions logistiques objectivent que le genre masculin du patient, du praticien et l'activité en zone urbaine serait protecteurs vis-à-vis du manque de données pour le vaccin dTP. L'exercice en milieu rural influe négativement sur la vaccination dTP. Conclusion : la couverture vaccinale reste déficiente au cabinet de médecine générale, 4%) dossiers. Les couvertures vaccinales prise individuellement et en excluant les données manquantes étaient de : 71 (75%)

, Mots clés : étude épidémiologique, vaccination, médecine générale, santé publique Abstract : Epidemiological Study on the Vaccination Coverage in the population of patient aged 75

. Years and . Older-in-picardy, According to the Study of 200 Patients Followed by General Practitioners of the, pp.2017-2018

, Background: Immunization coverage of eldery persons has never been studied on an epidemiological study at the general practice office

, Objective: the percentage of patients aged 75 years and older follow up on general practice office in Picardy, with an up-to-date immunization schedule

, Methods: study of 200 patients files recorded in 20 general practitioners offices settled in Picardy, pp.2017-2018

, Individual vaccine coverage and excluding missing data were : 71 (75%), 73 (71%), 1 (1.2%) for dTP, influenza and shingles. 28 (43.7%) of patients with a risk of invasive pneumococcal disease were not vaccinated. Influenza vaccine coverage is better among practitioners who are settled since less than 10 years (p = 0.0001). Our study found 75 (37.5%) medical files without any information available. The logistic regressions show that the male gender of the patient, practitioner and activity in the urban area is protective against the lack of data for the dTP vaccine

, Conclusion: Vaccine coverage remains deficient in the general practice, with a important loss of data in the medical files of patient follow up in general prationners offices. Keywords : Epidemiological study, vaccination